Developmental and Epileptic Encephalopathies Diagnosed Via Long-read Genome Sequencing

计划入组 20 人 · 首次发布于 2026 年 2 月 9 日

Study to Evaluate NBI-921352 as Adjunctive Therapy in Subjects With SCN8A Developmental and Epileptic Encephalopathy Syndrome (SCN8A-DEE)

计划入组 8 人 · 首次发布于 2021 年 5 月 5 日

Natural History Study of Infants and Children With Developmental and Epileptic Encephalopathies

计划入组 58 人 · 首次发布于 2020 年 9 月 3 日

Developmental and epileptic encephalopathy (Biogen)

STXB1 gene therapy (AAV, developmental and epileptic encephalopathy)

WWOX gene (spinocerebellar ataxia 12/developmental and epileptic encephalopathy)

BROOKDALE UNIVERSITY HOSPITAL MEDICAL CENTER

United States

SaNOtize Research and Development Corp

Canada

Aptevo Research And Development LLC

United States

Relutrigine Shows Promise in Reducing Seizures in SCN2A/SCN8A-DEE Phase 2 Trial

Praxis Precision Medicines Reports Positive EMBOLD Study Results for Relutrigine in Rare Epileptic Encephalopathies

Praxis Precision Medicines Advances CNS Pipeline with Key Clinical Milestones